1. Patenting at the UM Rene Vleugels Office of knowledge transfer

2. Patenting 1980-1999  No university policy  Decentral approach  Ownership for third parties  Royalty payments?

3. Patents 1980-1998

4. Patent Instructions UM  Ownership  Procedure  Obligations of the UM inventor  Financing of patents  Distribution of revenues

5. Patent Portfolio 2000-2003   Uitvinder(-s)Titel (afgekort)License   C. BruggemanAzetidinone derivaten -   P.C. DagnelieAdenosine trifostfaat in relatie tot kanker-   G. RietjesSchoenadapter -   M. DeutzTryptophan Concentration-   A. BastNovel flavenoidenSTW   P. FrederikVitrobotFEI   G. HaenenReductie toxiciteit van flavonoidenSTW   J. LuikenRegulator insuline-opname van de cel-   F. JongsmaDroge Cornea topograafStart-up   G. HagemanVoedingscomponenten als remmer van PARP-1STW   F. JongsmaRaman spectroscopyRE R’dam   M. EngelenVoedingssupplement GlutamaatRoche   B.Schutte K18 fragments and uses thereofMubio BV   W. HermensPEIA applications,,TNO   J. Plat ABC-G8 gen,,-   M.Pelzersbrain injury assay,,-   J. Maessen epicardial pace locator,,-   C. VermeerSerum marker diagnostiek van atheroscleroseVitak BV

6. Exploitation (1)  Licensing of patent to companies 1.Short description: flyer 2.Selection of companies 3.Identification of Contactpersons 4.Patent Assignment Agreement

7. Patent Assignment Agreement  Exclusivity vs. non-exclusivity  Specific applications  Exclusive status as CRO and Consultancy  Prevention of non-applicability  License Period  Up-front payment + Royalty payments  Milestone payment related to R&D development

8. Exploitation(2)  Basis for a start-up company  Entrepreneurship  Business Idea  Training  Business plan